GlaxoSmithkline Consumer Healthcare rose 1.6% to Rs 4,370 at 14:35 IST on BSE after net profit rose 14.5% to Rs 79.75 crore on 18.7% increase in total income to Rs 913.55 crore for the quarter to 31 December 2013 over the quarter to 31 December 2012.
The result was announced during trading hours today, 5 February 2014.
Meanwhile, the BSE Sensex was 40.31 points, or 0.20%, to 20,52.24.
On BSE, so far 932 shares were traded in the counter, compared with an average volume of 1,049 shares in the past one quarter.
The stock hit a high of Rs 4,395 and a low of Rs 4,290.05 so far during the day. The stock hit a record high of Rs 6,020 on 31 May 2013. The stock hit a 52-week low of Rs 3,645 on 23 April 2013.
The stock had outperformed the market over the past one month till 4 February 2014, falling 2.04% compared with the Sensex's 3.07% fall. The scrip had, however, underperformed the market in past one quarter, falling 7.95% as against Sensex's 4.84% decline.
Also Read
The large-cap company has an equity capital of Rs 42.06 crore. Face value per share is Rs 10.
GlaxoSmithkline Consumer Healthcare has changed its accounting year to April-March from earlier January-December. Therefore, the company's current accounting year has been extended till 31 March 2014 which is 15-month period.
GlaxoSmithkline Consumer Healthcare (GSK Consumer Healthcare) is a leading player in the malted food drinks segment. Its major brands include Horlicks, Boost, Viva and Maltova.
Powered by Capital Market - Live News